Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000

Clin Microbiol Infect. 2004 Aug;10(8):749-52. doi: 10.1111/j.1469-0691.2004.00954.x.

Abstract

Thirty HIV-seronegative cancer patients with active tuberculosis were evaluated. Eighteen (60%) were immigrants, 19 (63%) had haematological malignancy, and fever was the most common presentation (97%). Of 19 (63%) patients with pulmonary tuberculosis, 11 (58%) were misdiagnosed initially as suffering from cancer following radiography. Death was attributed to tuberculosis for six (21%) of 29 patients who received anti-mycobacterial therapy. All four patients who had received high-dose systemic corticosteroids within 4 weeks of diagnosis of infection died, whereas two (8%) deaths occurred in 25 individuals without corticosteroid exposure (p < 0.001; OR 8.67). At this institution, active tuberculosis was rare, and was seen mostly in immigrants. Recent high-dose corticosteroid therapy is a significant predictor of mortality in cancer patients with tuberculosis.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Cancer Care Facilities*
  • Hematologic Neoplasms / complications*
  • Hematologic Neoplasms / mortality
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis*
  • Tuberculosis, Pulmonary / complications*
  • Tuberculosis, Pulmonary / mortality*

Substances

  • Adrenal Cortex Hormones